Simultaneously, Mr. Hofer took on the role of CEO of Redox, a .406 portfolio company. Prior to his time at Optum, Mr. Hofer held leadership positions at CVS Health and UnitedHealth Group, according to a Nov. 15 .406 Ventures news release.
In his new role, Mr. Hofer will work to advise portfolio companies and identify investment opportunities. The venture firm focuses on early-stage investments in healthcare, data, cybersecurity and artificial intelligence companies.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
